Dow Down 0.62% Nasdaq Down 1.14%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
7.64 Down 0.39(4.86%) Sep 22, 4:15PM EDT
|After Hours : 7.70 Up 0.06 (0.79%) Sep 22, 4:38PM EDT
Prev Close:8.03
Open:7.99
Bid:7.60 x 100
Ask:7.69 x 300
1y Target Est:7.67
Beta:0.51
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:7.49 - 8.00
52wk Range:7.38 - 10.26
Volume:5,436,617
Avg Vol (3m):3,417,060
Market Cap:1.23B
P/E (ttm):4.40
EPS (ttm):1.74
Div & Yield:0.60 (6.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIDown 4.86%1.23B
AMGNDown 1.27%108.00B
SGENDown 1.40%4.94B
XOMADown 2.42%474.35M

Key Statistics

Forward P/E (1 yr):3.16
P/S (ttm):2.94
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.14
Quarterly EPS Est (Sep-14) :0.58
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback